Effect of nanoparticle exposure in a living system: probed by quantification of Fetuin-B in plasma proteome and kidney tissue imaging using MALDI imaging mass spectrometry in a rat model
Source abstract
Abstract
Nanoparticles have gained importance in various biomedical field viz cosmetics, diagnostics, therapeutics, and food additives. Due to small size, NPs penetrate tissues and cells, thereby interacting with biomolecules such as proteins and nucleic acids. This raises the major concern to investigate the effect of NPs in a living system. Previously, we reported downregulation of Fetuin-B in rat plasma, with the increasing dose level of NP-Fe4(P2O7)3, in rats treated with NP-Fe4(P2O7)3 as a food-fortificant. In the present study, we validated the dose response of Fetuin-B in rats exposed to NP-Fe4(P2O7)3, NP-ZnO, and NP-SiO2. Fetuin-B showed similar dose responses in all the groups irrespective of their physicochemical properties. Previously, we hypothesized that the immune response was triggered upon exposure to NP-Fe4(P2O7)3 in vivo, which led to the differential regulation of Fetuin-B. To evaluate the hypothesis, immunological response was assessed in rats by estimating the pro-inflammatory cytokines in plasma. We observed Interleukin-1α and Interleukin-1β increased with the increasing dose levels of the three NPs. The impact of NPs on the proteomic profile in the kidney tissues of rats exposed to three NPs, showed differential spatial distribution of α-Enolase across the medulla and the cortex region with respect to the control group, suggesting an overexpression of α-Enolase. Overexpression of α-Enolase might be an indicative of cellular apoptosis in response to cytotoxicity caused due to NP perforation across the cellular membrane. In the present study, we propose that Fetuin-B might be considered a plasma biomarker to detect nanotoxicity at an early stage in a living system.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. Arango Duque G, Descoteaux A (2014) Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol 5:491–49110.3389/fimmu.2014.00491 ↗
2. Brun E, Sicard-Roselli C (2014) Could nanoparticle corona characterization help for biological consequence prediction? Cancer Nanotechnol 5:7–710.1186/s12645-014-0007-5 ↗
3. Chen X, Mao SS (2007) Titanium dioxide nanomaterials: synthesis, properties, modifications, and applications. Chem Rev 107:2891–295910.1021/cr0500535 ↗
4. De Matteis V (2017) Exposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in vitro/in vivo toxicity evaluation. Toxics 5(4):2910.3390/toxics5040029 ↗
5. Díaz-Ramos À, Roig-Borrellas A, García-Melero A, López-Alemany R (2012) α -Enolase, a multifunctional protein: its role on pathophysiological situations. J Biomed Biotechnol 1–1210.1155/2012/156795 ↗
6. Dihazi H, Asif AR, Agarwal NK, Doncheva Y, Müller GA (2005) Proteomic analysis of cellular response to osmotic stress in Thick Ascending Limb of Henle’s loop (TALH) Cells. Mol Cell Proteomics 4:1445–145810.1074/mcp.M400184-MCP200 ↗
7. Dobrovolskaia MA, Patri AK, Simak J, Hall JB, Semberova J, Lacerda SHDP, McNeil SE (2012) Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro. Mol Pharm 9:382–38210.1021/mp200463e ↗
8. Dobrowolski L, Badzynska B, Walkowska A, Sadowski J (1998) Osmotic hypertonicity of the renal medulla during changes in renal perfusion pressure in the rat. J Physiol 508:929–93510.1111/j.1469-7793.1998.929bp.x ↗
9. Elsabahy M, Wooley KL (2013) Cytokines as biomarkers of nanoparticle immunotoxicity. Chem Soc Rev 42:5552–555210.1039/c3cs60064e ↗
10. Engin AB, Nikitovic D, Neagu M, Henrich-Noack P, Docea AO, Shtilman MI, Golokhvast K, Tsatsakis AM (2017) Mechanistic understanding of nanoparticles’ interactions with extracellular matrix: the cell and immune system. Part Fibre Toxicol 14:22–2210.1186/s12989-017-0199-z ↗
11. Gao Y, Gopee NV, Howard PC, Yu L-R (2011) Proteomic analysis of early response lymph node proteins in mice treated with titanium dioxide nanoparticles. J Proteomics 74:2745–275910.1016/j.jprot.2011.08.009 ↗
12. Grassian VH, Adamcakova-Dodd A, Pettibone JM, O’Shaughnessy PI, Thorne PS (2007) Inflammatory response of mice to manufactured titanium dioxide nanoparticles: comparison of size effects through different exposure routes. Nanotoxicology 1(3):211–22610.1080/17435390701694295 ↗
13. Grey AC, Chaurand P, Caprioli RM, Schey KL (2009) MALDI imaging mass spectrometry of integral membrane proteins from ocular lens and retinal tissue †. J Proteome Res 8:3278–328310.1021/pr800956y ↗
14. Guo L, Panderi I, Yan DD, Szulak K, Li Y, Chen Y-T, Ma H, Niesen DB, Seeram N, Ahmed A, Yan B, Pantazatos D, Lu W (2013) A comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity. ACS Nano 7:8780–879310.1021/nn403202w ↗
15. Hanley C, Thurber A, Hanna C, Punnoose A, Zhang J, Wingett DG (2009) The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res Lett 4:1409–142010.1007/s11671-009-9413-8 ↗
16. Hansen SF, Michelson ES, Kamper A, Borling P, Stuer-Lauridsen F, Baun A (2008) Categorization framework to aid exposure assessment of nanomaterials in consumer products. Ecotoxicology 17:438–44710.1007/s10646-008-0210-4 ↗
17. Higashisaka K, Yoshioka Y, Yamashita K, Morishita Y, Fujimura M, Nabeshi H, Nagano K, Abe Y, Kamada H, Tsunoda S-I, Yoshikawa T, Itoh N, Tsutsumi Y (2011) Acute phase proteins as biomarkers for predicting the exposure and toxicity of nanomaterials. Biomaterials 32:3–910.1016/j.biomaterials.2010.08.110 ↗
18. Hussain N, Jaitley V, Florence AT (2001) Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev 50:107–14210.1016/S0169-409X(01)00152-1 ↗
19. Iavicoli I, Fontana L, Nordberg G (2016) The effects of nanoparticles on the renal system. Crit Rev Toxicol 46:490–56010.1080/10408444.2016.1181047 ↗
20. Ishikawa F, Ushida K, Mori K, Shibanuma M (2015) Loss of anchorage primarily induces non-apoptotic cell death in a human mammary epithelial cell line under atypical focal adhesion kinase signaling. Cell Death Dis 6:e1619–e161910.1038/cddis.2014.583 ↗
21. Kermanizadeh A, Brown DM, Stone V (2019) The variances in cytokine production profiles from non- or activated THP-1 Kupffer Cell and Human Blood Derived Primary Macrophages following Exposure to Either Alcohol or a Panel of Engineered Nanomaterials. PLoS ONE 14:e0220974–e022097410.1371/journal.pone.0220974 ↗
22. King EJ (1928) The estimation of silica in tissues. J Biol Chem 80:25–3110.1016/S0021-9258(18)83903-5 ↗
23. Kusaczuk M, Krętowski R, Naumowicz M, Stypułkowska A, Cechowska-Pasko M (2018) Silica nanoparticle-induced oxidative stress and mitochondrial damage is followed by activation of intrinsic apoptosis pathway in glioblastoma cells. Int J Nanomed 13:2279–229410.2147/IJN.S158393 ↗
24. Lacroix R, Sabatier F, Mialhe A, Basire A, Pannell R, Borghi H, Robert S, Lamy E, Plawinski L, Camoin-Jau L, Gurewich V, Angles-Cano E, Dignat-George F (2007) Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood 110:2432–243910.1182/blood-2007-02-069997 ↗
25. Mahmoudi M, Shokrgozar MA, Sardari S, Moghadam MK, Vali H, Laurent S, Stroeve P (2011) Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. Nanoscale 3:1127–113810.1039/c1nr10326a ↗
26. McCullough JS, Hodges GM, Dickson GR, Yarwood A, Carr KE (1995) A morphological and microanalytical investigation into the uptake of particulate iron across the gastrointestinal tract of rats. J Submicrosc Cytol Pathol 27:119–124
27. Patil RM, Thorat ND, Shete PB, Bedge PA, Gavde S, Joshi MG, Tofail SAM, Bohara RA (2018) Comprehensive cytotoxicity studies of superparamagnetic iron oxide nanoparticles. Biochemistry and Biophysics Reports 13:63–7210.1016/j.bbrep.2017.12.002 ↗
28. Plow EF, Das R (2009) Enolase-1 as a plasminogen receptor. Blood 113:5371–537210.1182/blood-2009-03-208546 ↗
29. Rabolli V, Badissi AA, Devosse R, Uwambayinema F, Yakoub Y, Palmai-Pallag M, Lebrun A, De Gussem V, Couillin I, Ryffel B, Marbaix E, Lison D, Huaux F (2014) The alarmin IL-1α is a master cytokine in acute lung inflammation induced by silica micro- and nanoparticles. Part Fibre Toxicol 11:69–6910.1186/s12989-014-0069-x ↗
30. Rasmussen JW, Martinez E, Louka P, Wingett DG (2010) Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv 7:1063–107710.1517/17425247.2010.502560 ↗
31. Saptarshi SR, Duschl A, Lopata AL (2013) Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnol 11:26–2610.1186/1477-3155-11-26 ↗
32. Schwamborn K (2012) Imaging mass spectrometry in biomarker discovery and validation. J Proteomics 75:4990–499810.1016/j.jprot.2012.06.015 ↗
33. Schwamborn K, Caprioli RM (2010) Molecular imaging by mass spectrometry — looking beyond classical histology. Nat Rev Cancer 10:639–64610.1038/nrc2917 ↗
34. Scull CM, Hays WD, Fischer TH (2010) Macrophage pro-inflammatory cytokine secretion is enhanced following interaction with autologous platelets. J Inflamm 7:53–5310.1186/1476-9255-7-53 ↗
35. Singh N, Jenkins GJS, Asadi R, Doak SH (2010) Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 1(10):340210.3402/nano.v1i0.5358 ↗
36. Srinivasu BY, Mitra G, Muralidharan M, Srivastava D, Pinto J, Thankachan P, Suresh S, Shet A, Rao S, Ravikumar G, Thomas TS, Kurpad AV, Mandal AK (2015) Beneficiary effect of nanosizing ferric pyrophosphate as food fortificant in iron deficiency anemia: evaluation of bioavailability, toxicity and plasma biomarker. RSC Adv 5:61678–6168710.1039/C5RA07724A ↗
37. Srinivasu BY, Bose B, Mitra G, Kurpad AV, Mandal AK (2017) Adsorption induced changes of human hemoglobin on ferric pyrophosphate nanoparticle surface probed by isotope exchange mass spectrometry: an implication on structure-function correlation. Langmuir 33(32):8032–804210.1021/acs.langmuir.7b01905 ↗
38. Treuel L, Jiang X, Nienhaus GU (2013) New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface 10:20120939–2012093910.1098/rsif.2012.0939 ↗
39. Trouiller B, Reliene R, Westbrook A, Solaimani P, Schiestl RH (2009) Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Can Res 69:8784–878910.1158/0008-5472.CAN-09-2496 ↗
40. Ulisse S, D’Armiento M, Bocchini S, Baldini E (2011) Plasminogen-activating system. Berlin: Springer Berlin Heidelberg, pp 2904–2907
41. Warheit DB, Webb TR, Reed KL, Frerichs S, Sayes CM (2007) Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties. Toxicology 230:90–10410.1016/j.tox.2006.11.002 ↗
42. Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496:445–45510.1038/nature12034 ↗
43. Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I, Tschopp J (2010) Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc Natl Acad Sci USA 107:19449–1945410.1073/pnas.1008155107 ↗